(Q36843555)

16 August 2017

1 reference

title

Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China (English)

1 reference

16 August 2017

1 reference

1 reference

Guangbi Yao

1

1 reference

16 August 2017

language of work or name

English

0 references

publication date

6 June 2007

1 reference

Journal of Antimicrobial Chemotherapy

16 August 2017

published in

1 reference

16 August 2017

volume

60

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

201-205

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

16 August 2017

1 reference

Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM175

21 January 2018

Identifiers

DOI

10.1093/JAC/DKM175

1 reference

16 August 2017

1 reference